Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Bruce E Johnson

Showing results (191-200 of 241) with videos related to

Pageof 25
Sort By:
NPJ Precision Oncology|February 26, 2026
Tumor genomics in patients younger than 40 years of age with metastatic breast cancerKristen D Brantley, Ananya Kodali, Gregory J Kirkner, et al.
NPJ Precision Oncology|October 6, 2022
MatchMiner: an open-source platform for cancer precision medicineHarry Klein, Tali Mazor, Ethan Siegel, et al.
Cancer Discovery|May 16, 2012
The BATTLE trial: personalizing therapy for lung cancerEdward S Kim, Roy S Herbst, Ignacio I Wistuba, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|June 6, 2025
Updated Efficacy and Safety From the Phase 2 PHAROS Study of Encorafenib Plus Binimetinib in Patients With BRAF V600E-Mutant Metastatic NSCLC-A Brief ReportGregory J Riely, Myung-Ju Ahn, Jeffrey M Clarke, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 9, 2015
Detection of T790M, the Acquired Resistance EGFR Mutation, by Tumor Biopsy versus Noninvasive Blood-Based AnalysesTilak K Sundaresan, Lecia V Sequist, John V Heymach, et al.
Nature Communications|November 19, 2023
Comprehensive genomic characterization of HER2-low and HER2-0 breast cancerPaolo Tarantino, Hersh Gupta, Melissa E Hughes, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 12, 2005
Evolving concepts in the pathology and computed tomography imaging of lung adenocarcinoma and bronchioloalveolar carcinomaWilliam D Travis, Kavita Garg, Wilbur A Franklin, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|February 12, 2023
Clinicopathologic and Genomic Factors Impacting Efficacy of First-Line Chemoimmunotherapy in Advanced NSCLCJoao V Alessi, Arielle Elkrief, Biagio Ricciuti, et al.
Biorxiv : the Preprint Server for Biology|May 20, 2024
Clinicogenomic characterization of inflammatory breast cancerNolan Priedigkeit, Beth Harrison, Robert Shue, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|December 9, 2023
Artificial Intelligence-Powered Assessment of Pathologic Response to Neoadjuvant Atezolizumab in Patients With NSCLC: Results From the LCMC3 StudySanja Dacic, William D Travis, Jennifer M Giltnane, et al.
Pageof 25

Showing results (191-200 of 241) with videos related to

Sort By:
Pageof 25
NPJ Precision Oncology|February 26, 2026
Tumor genomics in patients younger than 40 years of age with metastatic breast cancerKristen D Brantley, Ananya Kodali, Gregory J Kirkner, et al.
NPJ Precision Oncology|October 6, 2022
MatchMiner: an open-source platform for cancer precision medicineHarry Klein, Tali Mazor, Ethan Siegel, et al.
Cancer Discovery|May 16, 2012
The BATTLE trial: personalizing therapy for lung cancerEdward S Kim, Roy S Herbst, Ignacio I Wistuba, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|June 6, 2025
Updated Efficacy and Safety From the Phase 2 PHAROS Study of Encorafenib Plus Binimetinib in Patients With BRAF V600E-Mutant Metastatic NSCLC-A Brief ReportGregory J Riely, Myung-Ju Ahn, Jeffrey M Clarke, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 9, 2015
Detection of T790M, the Acquired Resistance EGFR Mutation, by Tumor Biopsy versus Noninvasive Blood-Based AnalysesTilak K Sundaresan, Lecia V Sequist, John V Heymach, et al.
Nature Communications|November 19, 2023
Comprehensive genomic characterization of HER2-low and HER2-0 breast cancerPaolo Tarantino, Hersh Gupta, Melissa E Hughes, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 12, 2005
Evolving concepts in the pathology and computed tomography imaging of lung adenocarcinoma and bronchioloalveolar carcinomaWilliam D Travis, Kavita Garg, Wilbur A Franklin, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|February 12, 2023
Clinicopathologic and Genomic Factors Impacting Efficacy of First-Line Chemoimmunotherapy in Advanced NSCLCJoao V Alessi, Arielle Elkrief, Biagio Ricciuti, et al.
Biorxiv : the Preprint Server for Biology|May 20, 2024
Clinicogenomic characterization of inflammatory breast cancerNolan Priedigkeit, Beth Harrison, Robert Shue, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|December 9, 2023
Artificial Intelligence-Powered Assessment of Pathologic Response to Neoadjuvant Atezolizumab in Patients With NSCLC: Results From the LCMC3 StudySanja Dacic, William D Travis, Jennifer M Giltnane, et al.
Pageof 25